The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HIK HIKMA PHARMACEUTICALS PLC ORD SHS 10P




 Page 2 of 4

Previous | 1 | 2 | 3 | 4 | Next

Time/Date Code Headline Source Impact
14:01 29-Feb-2016 HIK Holding(s) in Company RNS -4.15% Down
13:59 29-Feb-2016 HIK Holding(s) in Company RNS -4.15% Down
13:47 29-Feb-2016 HIK Total Voting Rights RNS -4.15% Down
13:46 29-Feb-2016 HIK Roxane Acquisition Close RNS -4.15% Down
09:52 22-Feb-2016 HIK Directorate Change RNS +0.16% Up
12:55 19-Feb-2016 HIK EGM Statement RNS +0.04% Up
12:43 11-Feb-2016 HIK Holding(s) in Company RNS -8.80% Down
12:19 11-Feb-2016 HIK Circ re. Roxane Acquisition RNS -8.80% Down
10:38 10-Feb-2016 HIK Hikma Analyst and Investor Call RNS -10.05% Down
07:00 10-Feb-2016 HIK Circ re. Roxane Acquisition RNS -10.05% Down
14:04 22-Jan-2016 HIK Circ re. Roxane Acquisition and EGM RNS +0.93% Up
11:08 07-Jan-2016 HIK Total Voting Rights RNS -3.02% Down
07:52 24-Dec-2015 HIK Shareholders' Agreement and Board Appointment RNS +4.29% Up
09:38 17-Dec-2015 HIK Total Voting Rights RNS +5.46% Up
09:30 03-Dec-2015 HIK Director/PDMR Shareholding RNS -1.14% Down
08:45 25-Nov-2015 HIK Hikma announces sale of Ben Venue manufacturing RNS +2.67% Up
07:00 24-Nov-2015 HIK Holding(s) in Company RNS +3.18% Up
07:00 18-Nov-2015 HIK Resolution to FDA Warning Letter RNS +8.07% Up
15:04 16-Nov-2015 HIK Holding(s) in Company RNS +3.96% Up
16:16 11-Nov-2015 HIK Holding(s) in Company RNS -3.41% Down

 Page 2 of 4

Previous | 1 | 2 | 3 | 4 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address 13 Hanover Square, London, W1S 1HW, United Kingdom
Company website http://www.hikma.com
Market cap(in millions)* £ 5,276.06
Listing/Admission to trading 04 Nov 2005
Trading service SETS
Market MAINMARKET
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
03-May-16
FTSE index FTSE All-Share,FTSE 350 Low Yield,FTSE 250,FTSE All-Share (ex IT),FTSE 350 (ex IT),FTSE MID 250 (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment STMM
MiFID Status Regulated Market
Exchange market size 1,000
SEDOL B0LCW08
ISIN number GB00B0LCW083


Start trading your favourite asset CFDs!
Carries risk of capital loss



HIKMA share news analysis (HIK)